Published By : 01 Apr 2016 | Published By : QYRESEARCH
Biosensor devices are being used more and more in the medical fields. They are apt analytical devices that provide assistance in high end biological applications, such as biomimetic studies. Biosensors, in theory, are supposed to be programmable so that they can measure almost any biological value. The most common forms of biosensors that are currently in use today come in the form of antibodies or enzymes. Most of the people and companies associated to the global market of biosensors are almost always from the research and development field. This is a rather nascent market, and as such, researchers need to come up with something better at a consistent pace, in order to keep the global biosensors going at a consistent rate of research and development.
Wearable Tech and Biosensors Come Together
Companies such as VitalConnect are exploring the boundaries of the biosensors and their uses. The company had released its own batch of biosensors called VitalPatch. They are expected to greatly improve hospital care as well as home care services. The sensors can open up a completely new area of home care, where a consumer can opt for hospital-grade monitoring and medical attention right at home. It is a stick-on medical biosensor which will let patients avail monitoring services through a cloud-based healthcare system.
Fighting Cancer with Biosensors
Biosensors are also opening up new avenues in cancer research. Doctors can now diagnose their patients with cancer a whole lot earlier than was possible till now. This can be done through the use of an optical sensor that is supposedly a million times more sensitive than any related sensor in the market right now. The biosensor is small enough to fit in the doctor’s palm and can be used to detect early phase cancer related proteins that travel in a patient’s blood stream. These proteins in the early phase were extremely difficult to identify due to their minute quantities in the blood stream. Doctors can now use a commercialized version of the biosensor to detect these proteins and therefore allow them to figure out if a patient has cancer a lot earlier than what could be done before.